News

Cure for heart failure on horizon after scientists cure pigs with gene therapy

Our latest preclinical study, published in Nature Regenerative Medicine, was recently featured in The Telegraph. Click the link below to...
Read More

TikkunLev Therapeutics Announces the Publication of a Seminal Study in Nature Regenerative Medicine, Demonstrating the Potential Best-in-Class Profile of its cBIN1 Precision Therapy for Heart Failure

Best-in-Class Functional Recovery and Survival Benefits seen in an Established Large Animal Model of Pre-existing Severe Non-Ischemic Dilated Cardiomyopathy (DCM)...
Read More

TikkunLev Therapeutics Emerges from Stealth Mode

TikkunLev Therapeutics Emerges from Stealth Mode to Develop First-in-Class Precision Therapies for Heart Failure Targeting the Causal Disease Biology of...
Read More